Dr. Reddy’s Gets EMA Nod for ITUXREDI® Biosimilar, Eyes European Market Launch
July 29, 2024, 9:05 a.m.
Dr. Reddy’s Laboratories Ltd. has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for its proposed Rituximab biosi…
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.